Clinical Trials Browser

Phase 1/2 × Completed × Other solid neoplasm × Clear all

NCT00797719 2026-03-05

Short Neoadjuvant Hemithoracic IMRT for MPM

Phase 1/2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT04627740 2026-01-20

Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT06556108 2026-01-20

ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT03834272 2026-01-16

Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies

Phase 1/2 Completed

GastrointestinalGynecologicOther solid neoplasmThoracic

Gastrointestinal Neoplasms, Mesothelioma, Ovarian Neoplasms, Peritoneal Neoplasms

NCT04175847 2026-01-07

A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor

NCT05174585 2026-01-06

JAB-BX102 Monotherapy and Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor

NCT05774873 2026-01-06

The Primary Objective of This Study to Evaluate the Safety and Tolerability of IBI334 and Determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D)and Anti Tumor Activity of IBI334.

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT05307874 2025-12-24

EVICTION-2

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT05508334 2025-12-22

A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumours

NCT04381650 2025-12-10

A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors

Phase 1/2 Completed

161 enrolled 44 charts

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT05134948 2025-12-03

RELATIVITY 059

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT05991349 2025-11-25

A Study of IBI129 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor

NCT06170190 2025-11-17

A Multicentre,Study of IBI133 in Subjects WithUnresectable, Locally Advanced or Metastatic SolidTumours

Phase 1/2 Completed

Other solid neoplasm

Locally Advanced Unresectable or Metastatic Solid Tumors

NCT02875548 2025-11-04

TRuST

Phase 1/2 Completed

LymphoidOther solid neoplasmSarcomaThoracic

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Synovial, Lymphoma, Large B-Cell, Diffuse

NCT04497116 2025-10-21

TRESR

Phase 1/2 Completed

276 enrolled 33 charts

Other solid neoplasm

Advanced Solid Tumor

NCT03195478 2025-09-15

A Study of Nivolumab in Combination With Ipilimumab in Chinese Participants With Previously Treated Advanced or Recurrent Solid Tumors

Phase 1/2 Completed

37 enrolled 32 charts

Other solid neoplasm

Solid Tumor

NCT05161390 2025-09-12

Study of LM-302 in Patients With Advance Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumor

NCT05199753 2025-09-12

Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumor

NCT03126110 2025-08-14

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Phase 1/2 Completed

145 enrolled 47 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Neoplasm Metastasis, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT02428712 2025-07-29

A Study of FORE8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Unresectable Solid Tumors

NCT02611024 2025-07-09

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

Phase 1/2 Completed

CNSEndocrineGastrointestinalGynecologicNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Carcinoma, Ovarian Epithelial, Glioblastoma, Mesothelioma, Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Neuroendocrine Tumors

NCT04914286 2025-05-14

A Study of GFH018 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumor

NCT05830539 2025-05-02

IN10018 Combination Therapy in Previously-treated Locally Advanced or Metastatic Solid Tumor Patients

Phase 1/2 Completed

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT02649829 2025-04-29

MESODEC

Phase 1/2 Completed

GenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Wilms Tumor

NCT02913313 2025-04-20

A Study of BMS-986207 Given Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Advanced Solid Tumors

Phase 1/2 Completed

101 enrolled 34 charts

Other solid neoplasm

Broad Solid Tumor

NCT03523351 2025-04-20

Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain

Phase 1/2 Completed

78 enrolled 10 charts

Other solid neoplasm

Metastatic Solid Tumors of Metastatic Disease

NCT04720976 2025-04-11

JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasmThoracic

Solid Tumor

NCT03903705 2025-04-06

: A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumor

NCT04597541 2025-03-10

A Study of AK112 for Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT05188664 2025-02-17

Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumor

NCT03593226 2025-02-14

Study to Evaluate Safety & Tolerability of AGI-134 in Solid Tumour

Phase 1/2 Completed

38 enrolled 13 charts

Other solid neoplasm

Superficial, Palpable, Unresectable/Metastatic Solid Tumour

NCT02240238 2025-01-22

Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer

Phase 1/2 Completed

119 enrolled 24 charts

Other solid neoplasm

Solid Tumors

NCT04622774 2025-01-15

First-in-Human Study of IMGC936 in Participants With Advanced Solid Tumors

Phase 1/2 Completed

56 enrolled 21 charts

Other solid neoplasm

Advanced Solid Tumor

NCT01928394 2024-12-27

A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid Tumors

Phase 1/2 Completed

1,163 enrolled 33 charts 1 FDA

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT04020185 2024-12-11

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Phase 1/2 Completed

40 enrolled 16 charts

Other solid neoplasm

Solid Tumor, Adult

NCT01291420 2024-12-09

Dendritic Cell Vaccination for Patients with Solid Tumors

Phase 1/2 Completed

BreastCNSGastrointestinalGenitourinaryOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Renal Cell, Glioblastoma, Sarcoma, Colorectal Neoplasms

NCT04068519 2024-10-26

Study Investigating Safety, Tolerability, Pharmacokinetics (PK) and Antitumor Activities of Anti-PD-1 (Programmed Death-1) Monoclonal Antibody

Phase 1/2 Completed

300 enrolled 23 charts

Other solid neoplasm

Advanced Solid Tumors

NCT04174716 2024-09-27

VASTUS

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT04645069 2024-08-14

ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT04121442 2024-08-06

Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT01283945 2024-07-25

Study of Oral Lucitanib (E-3810), a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT04856774 2024-06-27

Trial of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT04001075 2024-04-15

Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TJ107 in Chinese Patients With Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumord

NCT01543698 2024-03-13

A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors

Phase 1/2 Completed

189 enrolled 44 charts

Other solid neoplasm

Solid Tumors Harboring a BRAF V600 Mutation

NCT03399552 2023-10-23

Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

Phase 1/2 Completed

15 enrolled 8 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT03834948 2023-08-22

AO-176 in Multiple Solid Tumor Malignancies

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor

NCT02598960 2023-03-06

An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread.

Phase 1/2 Completed

295 enrolled 28 charts

Other solid neoplasm

Solid Tumors

NCT04592484 2023-02-08

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumor

NCT04481009 2022-12-12

A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT02593786 2022-10-24

CheckMate 077

Phase 1/2 Completed

58 enrolled 31 charts

Other solid neoplasm

Solid Tumors